Analysis of Predictive and Preventive Factors for De Novo DSA in Kidney Transplant Recipients

Class II HLA Epitope Matching-A Strategy to MinimizeDe NovoDonor-Specific Antibody Development and Improve Outcomes

(2013) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

(2013) H. Kaneku et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

(2013) Matthew J. Everly et al.   TRANSPLANTATION

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

(2012) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients WithDe NovoDonor-Specific Antibodies

(2012) H. de Kort et al.   AMERICAN JOURNAL OF TRANSPLANTATION

PosttransplantDe NovoDonor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection

(2012) F. Ginevri et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection

(2012) Toshihito Hirai et al.   TRANSPLANT INTERNATIONAL

IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up

(2012) Heiko Billing et al.   TRANSPLANT INTERNATIONAL

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy

(2012) Michelle Willicombe et al.   TRANSPLANTATION

Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

(2012) Brian D. Tait et al.   TRANSPLANTATION

Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period

(2011) N. Kohei et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Comparison of the Acute Rejection Incidence Rate in Spousal Donor Transplantation Before and After Anti-CD20 Antibody (Rituximab) Protocol as Desensitization Therapy

(2011) Toshihito Hirai et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules

(2011) Irma-Sofia A. Ntokou et al.   TRANSPLANT INTERNATIONAL

Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes

(2011) James E. Cooper et al.   TRANSPLANTATION

Impact of Pretransplant Human Leukocyte Antigen-C and -DP Antibodies on Kidney Graft Outcome

(2011) M. Gilbert et al.   TRANSPLANTATION PROCEEDINGS

Changes in anti-HLA antibody titers more than 1year after desensitization therapy with rituximab in living-donor kidney transplantation

(2010) Toshio Takagi et al.   TRANSPLANT IMMUNOLOGY

Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation

(2010) Toshio Takagi et al.   TRANSPLANTATION

Acute Humoral Rejection in a Zero Mismatch Deceased Donor Renal Transplant Due to an Antibody to an HLA-DP α

(2010) Pooja Singh et al.   TRANSPLANTATION

Acute Antibody-Mediated Rejection in Living ABO-Incompatible Kidney Transplantation: Long-Term Impact and Risk Factors

(2009) D. Toki et al.   AMERICAN JOURNAL OF TRANSPLANTATION

De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

(2009) L. G. Hidalgo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

(2009) M. J. Everly et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection

(2009) C. Lefaucheur et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant

(2009) Vincent Aubert et al.   HUMAN IMMUNOLOGY

Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: Insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation

(2009) Olivier Thaunat et al.   TRANSPLANT IMMUNOLOGY

Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts

(2009) Nils Lachmann et al.   TRANSPLANTATION

A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation

(2009) Gunnar Tydén et al.   TRANSPLANTATION

Four Stages and Lack of Stable Accommodation in Chronic Alloantibody-Mediated Renal Allograft Rejection in Cynomolgus Monkeys

(2008) R. N. Smith et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Poor graft outcome in recipients withde novodonor-specific anti-HLA antibodies after living related kidney transplantation

(2008) Xiaobei Li et al.   TRANSPLANT INTERNATIONAL